Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Rullier

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Annals of Diagnostic Pathology|September 21, 2023
Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategiesAlexis Trecourt, Pierre-Jean Cottinet, Marie Donzel, et al.
Hepatology Communications|February 7, 2018
MicroRNA therapy inhibits hepatoblastoma growth <i>in vivo</i> by targeting β-catenin and Wnt signalingEmilie Indersie, Sarah Lesjean, Katarzyna B Hooks, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2012
A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiationRunjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
Annales De Pathologie|December 17, 2011
[Locally advanced rectal cancer management: which role for the pathologist in 2011?]Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, et al.
Lancet (London, England)|June 12, 2017
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trialEric Rullier, Philippe Rouanet, Jean-Jacques Tuech, et al.
Human Pathology|May 12, 2012
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systemsRunjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
JHEP Reports : Innovation in Hepatology|May 8, 2023
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1Caroline Gest, Sandra Sena, Lydia Dif, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
New insights into diagnosis and therapeutic options for proliferative hepatoblastomaKatarzyna B Hooks, Jérôme Audoux, Helena Fazli, et al.
The Lancet. Gastroenterology & Hepatology|February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trialEric Rullier, Véronique Vendrely, Julien Asselineau, et al.
Human Pathology|May 6, 2019
Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF<sup>V600E</sup> mutation study from the French national cohortMarianne Kambouchner, Jean-François Emile, Marie-Christine Copin, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Annals of Diagnostic Pathology|September 21, 2023
Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategiesAlexis Trecourt, Pierre-Jean Cottinet, Marie Donzel, et al.
Hepatology Communications|February 7, 2018
MicroRNA therapy inhibits hepatoblastoma growth <i>in vivo</i> by targeting β-catenin and Wnt signalingEmilie Indersie, Sarah Lesjean, Katarzyna B Hooks, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2012
A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiationRunjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
Annales De Pathologie|December 17, 2011
[Locally advanced rectal cancer management: which role for the pathologist in 2011?]Frédéric Bibeau, Anne Rullier, Marie-Françoise Jourdan, et al.
Lancet (London, England)|June 12, 2017
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trialEric Rullier, Philippe Rouanet, Jean-Jacques Tuech, et al.
Human Pathology|May 12, 2012
International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systemsRunjan Chetty, Pelvender Gill, Dhirendra Govender, et al.
JHEP Reports : Innovation in Hepatology|May 8, 2023
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1Caroline Gest, Sandra Sena, Lydia Dif, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
New insights into diagnosis and therapeutic options for proliferative hepatoblastomaKatarzyna B Hooks, Jérôme Audoux, Helena Fazli, et al.
The Lancet. Gastroenterology & Hepatology|February 12, 2020
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trialEric Rullier, Véronique Vendrely, Julien Asselineau, et al.
Human Pathology|May 6, 2019
Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF<sup>V600E</sup> mutation study from the French national cohortMarianne Kambouchner, Jean-François Emile, Marie-Christine Copin, et al.
Pageof 8